HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javier Zudaire Selected Research

Prostatic Neoplasms (Prostate Cancer)

5/2014Survival analysis of patients with biochemical relapse after radical prostatectomy treated with androgen deprivation: Castration-resistance influential factors.
10/2013Radical prostatectomy. Prognostic value of positive surgical margins in pT2 patients.
4/2010Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.
2/2010Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javier Zudaire Research Topics

Disease

4Prostatic Neoplasms (Prostate Cancer)
05/2014 - 02/2010
2Margins of Excision
04/2014 - 10/2013
1Adenocarcinoma
07/2013
1Neoplasms (Cancer)
02/2010

Drug/Important Bio-Agent (IBA)

1Glucose (Dextrose)FDA LinkGeneric
04/2010
1Prostate-Specific Antigen (Semenogelase)IBA
02/2010
1AndrogensIBA
02/2010
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
02/2010

Therapy/Procedure

4Prostatectomy (Retropubic Prostatectomy)
05/2014 - 07/2013
1PET protocol
04/2010
1Therapeutics
02/2010
1Conformal Radiotherapy
02/2010
1Brachytherapy
02/2010
1Radiotherapy
02/2010